Cardiff Oncology, Inc. (CRDF) Share-based Payment Arrangement, Expense USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cardiff Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2024.
  • Cardiff Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $1.12 M, a 5.64% increase year-over-year.
  • Cardiff Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $4.57 M, a 9.62% increase year-over-year.
  • Cardiff Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.51 M, a 5.95% increase from 2022.
  • Cardiff Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.26 M, a 31.6% increase from 2021.
  • Cardiff Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.23 M, a 83.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.57 M $1.12 M +$60 K +5.64% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $4.51 M $909 K -$103 K -10.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $4.61 M $955 K -$82 K -7.91% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $4.69 M $1.58 M +$526 K +49.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $4.17 M $1.06 M -$88 K -7.64% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $4.26 M $1.01 M +$22 K +2.22% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $4.23 M $1.04 M +$97 K +10.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $4.14 M $1.06 M +$19 K +1.83% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $4.12 M $1.15 M +$884 K +330% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $3.23 M $990 K +$46 K +4.87% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $3.19 M $940 K +$578 K +160% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.61 M $1.04 M +$754 K +267% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.86 M $268 K +$91 K +51.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.77 M $944 K +$674 K +250% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $1.09 M $362 K +$95.7 K +35.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $995 K $282 K +$133 K +89.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $862 K $177 K -$23.1 K -11.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $885 K $270 K +$742 +0.28% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $884 K $266 K -$11.9 K -4.28% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $896 K $149 K -$72.5 K -32.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $969 K $200 K -$1.21 M -85.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $2.17 M $269 K -$626 K -70% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $2.8 M $278 K -$1.14 M -80.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $3.94 M $221 K -$554 K -71.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $4.5 M $1.41 M +$485 K +52.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $4.01 M $895 K -$667 K -42.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 $4.68 M $1.42 M -$408 K -22.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $5.09 M $775 K -$527 K -40.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $5.61 M $921 K -$1.89 M -67.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $7.5 M $1.56 M +$375 K +31.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-26
Q3 2016 $7.13 M $1.83 M +$906 K +98.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $6.22 M $1.3 M +$178 K +15.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $6.05 M $2.81 M +$2.1 M +295% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $3.95 M $1.19 M +$502 K +73.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 $3.44 M $924 K +$518 K +128% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $2.93 M $1.12 M +$704 K +168% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $2.22 M $712 K +$152 K +27.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $2.07 M $685 K +$364 K +113% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $1.71 M $406 K -$563 K -58.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $2.27 M $419 K +$72.1 K +20.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $2.2 M $560 K +$218 K +63.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $1.98 M $321 K +$138 K +75.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 $1.84 M $969 K +$839 K +643% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $1 M $347 K +$232 K +200% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $771 K $341 K +$239 K +232% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $532 K $183 K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $130 K +$47.4 K +57.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $116 K +$55.5 K +92.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $103 K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q3 2011 $83 K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $60.3 K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.